Published in Diagn Cytopathol on January 12, 2012
The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract (2011) 3.79
Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol (2011) 3.50
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol (2003) 2.77
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol (2012) 2.17
Clinical features of bladder cancer in primary care. Br J Gen Pract (2012) 1.89
The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal (2010) 1.72
Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract (2005) 1.59
Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract (2011) 1.59
Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. Br J Gen Pract (2013) 1.45
Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. BMC Blood Disord (2011) 1.36
The surgical management of sacral chordomas. Spine (Phila Pa 1976) (2009) 1.24
Will widgets and semantic tagging change computational biology? PLoS Comput Biol (2010) 1.21
Prospective study of elderly people comparing treatments following first primary care consultation for a symptomatic hip or knee. Fam Pract (2004) 1.14
Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial. Gynecol Oncol (2012) 1.14
Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nucl Med (2003) 1.14
S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol (2009) 1.13
Impact of persistent hip or knee pain on overall health status in elderly people: a longitudinal population study. Arthritis Rheum (2005) 1.12
Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. Antioxid Redox Signal (2010) 1.10
Clinical features of kidney cancer in primary care: a case-control study using primary care records. Br J Gen Pract (2013) 1.09
Views of cancer care reviews in primary care: a qualitative study. Br J Gen Pract (2011) 1.08
Resilin and chitinous cuticle form a composite structure for energy storage in jumping by froghopper insects. BMC Biol (2008) 1.07
A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. Gynecol Oncol (2012) 1.06
Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J (2004) 1.06
Population survey comparing older adults with hip versus knee pain in primary care. Br J Gen Pract (2005) 1.05
Diagnosis using "test of treatment". BMJ (2009) 1.03
Hypoxia-inducible factor-1α is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress. Biol Pharm Bull (2010) 1.03
Pharmacokinetics of linagliptin in subjects with hepatic impairment. Br J Clin Pharmacol (2012) 1.00
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy. Gynecol Oncol (2002) 0.99
In the absence of evidence, who chooses? A qualitative study of patients' needs after treatment for colorectal cancer. J Health Serv Res Policy (2004) 0.97
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol (2012) 0.97
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran. Emerg Med J (2013) 0.95
Intrathoracic fracture-dislocation of the proximal humerus: a case report and report of a new surgical technique. J Trauma (2007) 0.95
Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery. Skull Base (2010) 0.94
Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol (2011) 0.94
"I wish I'd told them": a qualitative study examining the unmet psychosexual needs of prostate cancer patients during follow-up after treatment. Patient Educ Couns (2010) 0.94
The Coenzyme Q10 analog decylubiquinone inhibits the redox-activated mitochondrial permeability transition: role of mitcohondrial [correction mitochondrial] complex III. J Biol Chem (2003) 0.94
Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects. Drug Metab Pharmacokinet (2010) 0.92
Partners and close family members of long-term cancer survivors: health status, psychosocial well-being and unmet supportive care needs. Psychooncology (2011) 0.92
Hydrogen sulfide is an endogenous regulator of aging in Caenorhabditis elegans. Antioxid Redox Signal (2013) 0.92
Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear. Acta Cytol (2002) 0.91
Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition. Free Radic Biol Med (2005) 0.90
DISCERN-Genetics: quality criteria for information on genetic testing. Eur J Hum Genet (2006) 0.89
Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88
The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cell Signal (2006) 0.87
Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecol Oncol (2008) 0.86
A randomized, open-label, crossover study to evaluate the pharmacokinetics of empagliflozin and linagliptin after coadministration in healthy male volunteers. Clin Ther (2013) 0.84
Oncologic conditions that simulate common sports injuries. J Am Acad Orthop Surg (2014) 0.84
Bowel cancer screening in England: a qualitative study of GPs' attitudes and information needs. BMC Fam Pract (2006) 0.83
Pain and overall health status in older people with hip and knee replacement: a population perspective. J Public Health (Oxf) (2006) 0.82
Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers. Clin Ther (2013) 0.82
Mechanical reconfiguration mediates swallowing and rejection in Aplysia californica. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2006) 0.81
Locusts use a composite of resilin and hard cuticle as an energy store for jumping and kicking. J Exp Biol (2012) 0.80
Nitrite-mediated protection against hypochlorous acid-induced chondrocyte toxicity: a novel cytoprotective role of nitric oxide in the inflamed joint? Arthritis Rheum (2003) 0.80
Ovarian carcinosarcoma: effects of cytoreductive status and platinum-based chemotherapy on survival. Obstet Gynecol Int (2013) 0.79
Mass balance and metabolite profiling of steady-state faldaprevir, a hepatitis C virus NS3/4 protease inhibitor, in healthy male subjects. Antimicrob Agents Chemother (2014) 0.79
More on thromboprophylaxis: quantifying risk for venous thromboembolism. Thromb Haemost (2009) 0.78
beta-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics (2005) 0.78
Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers. Gynecol Oncol (2004) 0.77
Inhibition of hypochlorous acid-induced oxidative reactions by nitrite: is nitrite an antioxidant? Biochem Biophys Res Commun (2003) 0.75
Risk factors for cancer-associated venous thromboembolism in outpatient deep venous thrombosis clinics. Br J Haematol (2010) 0.75
Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study). BMC Cardiovasc Disord (2013) 0.75
Venous thromboembolism registry: a route to improved patient outcomes. Hosp Med (2004) 0.75
Is quinsy often managed in the community? Br J Gen Pract (2002) 0.75
Prediction of colorectal cancer by consultation questionnaire. Lancet (2002) 0.75
Warfarin and calcific uremic arteriolopathy. BMJ Case Rep (2009) 0.75
Toxicity associated with carboplatin/paclitaxel/Irinotecan use in advanced ovarian cancer: preliminary analysis. Oncology (Williston Park) (2003) 0.75
Endometrial stromal sarcomas--clarification. Gynecol Oncol (2008) 0.75
Pilot study of early diagnosis of hereditary haemochromatosis through systematic case finding in primary care. Community Genet (2002) 0.75
Impact of venous thromboembolism on survival in patients with malignancy. Br J Haematol (2009) 0.75
Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers. J Clin Pharmacol (2014) 0.75
The R2464C missense mutation in the von Willebrand factor gene causes a novel abnormality of multimer electrophoretic mobility and falls into the subgroup of type 2 von Willebrand disease 'unclassified'. Thromb Haemost (2007) 0.75
Tissue pathway factor inhibitor (TFPI) activity is elevated in pregnant patients at 20 weeks gestation who subsequently develop preeclampsia. Thromb Haemost (2009) 0.75
Activation of proteases in an anaerobic sulphidogenic bioreactor. Biotechnol Lett (2004) 0.75
Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tablet . Int J Clin Pharmacol Ther (2017) 0.75
The 2011 North American Traveling Fellowship. J Bone Joint Surg Am (2012) 0.75
Hand-Assisted Robotic Surgery for Staging of Ovarian Cancer and Uterine Cancers With High Risk of Peritoneal Spread: A Retrospective Cohort Study. Int J Gynecol Cancer (2015) 0.75
Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients. Am J Health Syst Pharm (2012) 0.75